Company / Current Liabilities per Share
Summit Therapeutics Inc. Current Liabilities per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.10
FY2025
5-year range
$0.06 / $0.40
FY2021-FY2025
Trend
+64.1%
vs FY2024
Sector context
#205 of 210
Health Care
What the data says
Among 210 Health Care companies, Summit Therapeutics Inc. is in the top 2% for current liabilities per share. Current Liabilities per Share returned to growth in FY2025 after 2 years of decline, reaching $0.10.
Based on SEC 10-K filings.
0.10 in FY2025 with a 5-year CAGR of -19.9%.
Remained stable around $0.10 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- -37.3%
- 5-Year CAGR
- -19.9%
- 10-Year CAGR
- -
Sector benchmark
Top 2% in Health CareTop 2% of 210This company $0.10 Sector average $23.79
▼
-99.6% below sector average
Key checks
Key Insights
- In FY2025, current liabilities per share increased 64.1% year-over-year.
- Ranks #205 out of 210 companies in the Health Care sector.
- Peak current liabilities per share was recorded in FY2019.
- Lowest current liabilities per share in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.10 | +64.1% |
| FY2024 | $0.06 | -38.5% |
| FY2023 | $0.10 | -75.6% |
| FY2022 | $0.40 | +419.0% |
| FY2021 | $0.08 | -74.3% |
| FY2020 | $0.30 | -29.4% |
| FY2019 | $0.42 | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026